Oppenheimer Asset Management Inc. Acquires 554 Shares of U.S. Physical Therapy, Inc. (USPH)

Share on StockTwits

Oppenheimer Asset Management Inc. lifted its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 10.4% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,870 shares of the company’s stock after acquiring an additional 554 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in U.S. Physical Therapy were worth $697,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also bought and sold shares of USPH. Acadian Asset Management LLC acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at $106,000. Cambridge Investment Research Advisors Inc. acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at $219,000. Itau Unibanco Holding S.A. acquired a new position in shares of U.S. Physical Therapy during the 2nd quarter valued at $235,000. PNC Financial Services Group Inc. lifted its holdings in shares of U.S. Physical Therapy by 62.7% during the 2nd quarter. PNC Financial Services Group Inc. now owns 2,676 shares of the company’s stock valued at $256,000 after acquiring an additional 1,031 shares in the last quarter. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS acquired a new position in U.S. Physical Therapy in the 2nd quarter worth $257,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

A number of equities analysts have commented on USPH shares. Barrington Research reiterated a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 price objective on the stock in a report on Tuesday, August 7th. Jefferies Financial Group reiterated a “hold” rating and issued a $105.00 price objective on shares of U.S. Physical Therapy in a report on Friday, August 3rd. Cantor Fitzgerald boosted their price objective on shares of U.S. Physical Therapy from $103.00 to $107.00 and gave the stock a “neutral” rating in a report on Friday, November 2nd. Finally, TheStreet lowered shares of U.S. Physical Therapy from a “b” rating to a “c+” rating in a report on Friday, November 2nd. Four research analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $113.67.

In other news, CEO Christopher J. Reading sold 8,768 shares of the business’s stock in a transaction dated Tuesday, August 14th. The shares were sold at an average price of $115.57, for a total value of $1,013,317.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Mark J. Brookner sold 625 shares of the business’s stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $128.50, for a total transaction of $80,312.50. The disclosure for this sale can be found here. Insiders sold a total of 22,618 shares of company stock worth $2,617,792 in the last quarter. 2.50% of the stock is currently owned by company insiders.

Shares of USPH stock opened at $114.46 on Wednesday. U.S. Physical Therapy, Inc. has a 12 month low of $64.45 and a 12 month high of $129.65. The company has a current ratio of 1.93, a quick ratio of 2.06 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $1.43 billion, a price-to-earnings ratio of 55.03, a PEG ratio of 3.95 and a beta of 1.19.

U.S. Physical Therapy (NYSE:USPH) last issued its quarterly earnings data on Thursday, November 1st. The company reported $0.64 EPS for the quarter, topping analysts’ consensus estimates of $0.58 by $0.06. U.S. Physical Therapy had a net margin of 5.58% and a return on equity of 17.64%. The firm had revenue of $113.10 million for the quarter, compared to analyst estimates of $112.79 million. The company’s quarterly revenue was up 9.8% compared to the same quarter last year. Sell-side analysts forecast that U.S. Physical Therapy, Inc. will post 2.54 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Friday, November 9th will be issued a $0.23 dividend. The ex-dividend date is Thursday, November 8th. This represents a $0.92 dividend on an annualized basis and a yield of 0.80%. U.S. Physical Therapy’s dividend payout ratio is currently 44.23%.

TRADEMARK VIOLATION WARNING: “Oppenheimer Asset Management Inc. Acquires 554 Shares of U.S. Physical Therapy, Inc. (USPH)” was originally published by Week Herald and is the sole property of of Week Herald. If you are reading this report on another publication, it was copied illegally and republished in violation of international copyright and trademark laws. The legal version of this report can be viewed at https://weekherald.com/2018/11/07/oppenheimer-asset-management-inc-acquires-554-shares-of-u-s-physical-therapy-inc-usph.html.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Story: What are defining characteristics of a correction?

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply